Studying & Developing Bispecific ADCs From Early Discovery to IND-Enabling Studies

  • Exploring bispecific ADCs as an emerging and promising next-generation ADC modality
  • Outlining the rationale behind target combinations for bispecific ADC design
  • Assessing the preclinical safety and efficacy of bispecific ADCs in comparison to monospecific ADCs for clinical trials